Analyst Research

Report Title Price
Korea Bone Bank Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Korea Bone Bank CO.,LTD.: Summary Due Dilligence Report
Provider: SADIF-Investment Analytics, S.A.
$115.00
Buy
Korea Bone Bank CO.,LTD.: Summary Due Dilligence Report
Provider: SADIF-Investment Analytics, S.A.
$25.00
Buy
Korea Bone Bank Inc. (049180) - Product Pipeline Summary
Provider: GlobalData
$300.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Korea Bone Bank CO.,LTD. Receives KFDA Approval


Thursday, 20 Oct 2011 01:44am EDT 

Korea Bone Bank CO.,LTD. announced that it has received Korea Food & Drug Administration (KFDA) approval, on October 20, 2011, to manufacture pallas navigation. 

Latest Developments for Cellumed Co Ltd

Latest Key Developments in Medical

Company Quote

Cellumed Co Ltd
(049180.KQ)
4780.0
10.0 +0.21%
19 Jun 2013